G1 THERAPEUTICS, INC. Research and Development Expense
G1 THERAPEUTICS, INC. reported Research and Development Expense of $5.74 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2024-08-08
- G1 THERAPEUTICS, INC. research and development expense for the quarter ending 2024-06-30 was $5.74M, a 52.34% decline year-over-year.
- G1 THERAPEUTICS, INC. research and development expense for the quarter ending 2024-03-31 was $7.32M, a 52.73% decline year-over-year.
- G1 THERAPEUTICS, INC. research and development expense for the quarter ending 2023-12-31 was $7.38M, a 55.51% decline year-over-year.
- G1 THERAPEUTICS, INC. research and development expense for the quarter ending 2023-09-30 was $8.81M, a 55.00% decline year-over-year.
- G1 THERAPEUTICS, INC. research and development expense for fiscal 2023 was $43.71M, a 47.54% decline from fiscal 2022.
- G1 THERAPEUTICS, INC. research and development expense for fiscal 2022 was $83.32M, a 9.30% increase from fiscal 2021.
- G1 THERAPEUTICS, INC. research and development expense for fiscal 2021 was $76.22M, a 4.03% increase from fiscal 2020.
- G1 THERAPEUTICS, INC. research and development expense for fiscal 2020 was $73.27M, a 17.67% decline from fiscal 2019.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $5.74M 10-Q · filed 2024-08-08 | $13.06M 10-Q · filed 2024-08-08 | $20.44M derived: sum of 3 quarters · filed 2024-08-08 | $29.25M derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | $7.32M 10-Q · filed 2024-05-01 | $14.70M derived: sum of 2 quarters · filed 2024-05-01 | $23.51M derived: sum of 3 quarters · filed 2024-05-01 | $35.55M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-12-31 | $7.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $16.19M derived: sum of 2 quarters · filed 2024-02-28 | $28.23M derived: sum of 3 quarters · filed 2024-08-08 | $43.71M 10-K · filed 2024-02-28 |
| 2023-09-30 | $8.81M 10-Q · filed 2023-11-01 | $20.85M derived: sum of 2 quarters · filed 2024-08-08 | $36.33M 10-Q · filed 2023-11-01 | $52.92M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-06-30 | $12.04M 10-Q · filed 2024-08-08 | $27.52M 10-Q · filed 2024-08-08 | $44.11M derived: sum of 3 quarters · filed 2024-08-08 | $63.69M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $15.48M 10-Q · filed 2024-05-01 | $32.07M derived: sum of 2 quarters · filed 2024-05-01 | $51.65M derived: sum of 3 quarters · filed 2024-05-01 | $72.49M derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | $16.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $36.17M derived: sum of 2 quarters · filed 2024-02-28 | $57.01M derived: sum of 3 quarters · filed 2024-02-28 | $83.32M 10-K · filed 2024-02-28 |
| 2022-09-30 | $19.58M 10-Q · filed 2023-11-01 | $40.42M derived: sum of 2 quarters · filed 2023-11-01 | $66.73M 10-Q · filed 2023-11-01 | $86.52M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $20.84M 10-Q · filed 2023-08-02 | $47.15M 10-Q · filed 2023-08-02 | $66.94M derived: sum of 3 quarters · filed 2024-02-28 | $88.08M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $26.30M 10-Q · filed 2023-05-03 | $46.09M derived: sum of 2 quarters · filed 2024-02-28 | $67.24M derived: sum of 3 quarters · filed 2024-02-28 | $85.99M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $19.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $40.93M derived: sum of 2 quarters · filed 2024-02-28 | $59.69M derived: sum of 3 quarters · filed 2024-02-28 | $76.22M 10-K · filed 2024-02-28 |
| 2021-09-30 | $21.14M 10-Q · filed 2022-11-02 | $39.90M derived: sum of 2 quarters · filed 2022-11-02 | $56.44M 10-Q · filed 2022-11-02 | $72.81M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $18.75M 10-Q · filed 2022-08-03 | $35.29M 10-Q · filed 2022-08-03 | $51.67M derived: sum of 3 quarters · filed 2023-03-01 | $69.60M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $16.54M 10-Q · filed 2022-05-04 | $32.91M derived: sum of 2 quarters · filed 2023-03-01 | $50.85M derived: sum of 3 quarters · filed 2023-03-01 | $69.38M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $16.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $34.31M derived: sum of 2 quarters · filed 2023-03-01 | $52.84M derived: sum of 3 quarters · filed 2023-03-01 | $73.27M 10-K · filed 2023-03-01 |
| 2020-09-30 | $17.93M 10-Q · filed 2021-11-03 | $36.46M derived: sum of 2 quarters · filed 2021-11-03 | $56.90M 10-Q · filed 2021-11-03 | $81.39M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $18.53M 10-Q · filed 2021-08-04 | $38.97M 10-Q · filed 2021-08-04 | $63.46M derived: sum of 3 quarters · filed 2022-02-23 | $86.40M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $20.43M 10-Q · filed 2021-05-05 | $44.93M derived: sum of 2 quarters · filed 2022-02-23 | $67.87M derived: sum of 3 quarters · filed 2022-02-23 | $91.36M derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | $24.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $47.43M derived: sum of 2 quarters · filed 2022-02-23 | $70.92M derived: sum of 3 quarters · filed 2022-02-23 | $89.00M 10-K · filed 2022-02-23 |
| 2019-09-30 | $22.94M 10-Q · filed 2020-11-04 | $46.43M derived: sum of 2 quarters · filed 2020-11-04 | $64.51M 10-Q · filed 2020-11-04 | $83.59M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $23.49M 10-Q · filed 2020-08-05 | $41.57M 10-Q · filed 2020-08-05 | $60.65M derived: sum of 3 quarters · filed 2021-02-24 | $76.52M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $18.08M 10-Q · filed 2020-05-06 | $37.16M derived: sum of 2 quarters · filed 2021-02-24 | $53.03M derived: sum of 3 quarters · filed 2021-02-24 | $71.42M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $19.08M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $34.95M derived: sum of 2 quarters · filed 2021-02-24 | $53.34M derived: sum of 3 quarters · filed 2021-02-24 | $70.68M 10-K · filed 2021-02-24 |
| 2018-09-30 | $15.87M 10-Q · filed 2019-11-05 | $34.26M derived: sum of 2 quarters · filed 2019-11-05 | $51.60M 10-Q · filed 2019-11-05 | $66.68M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $18.39M 10-Q · filed 2019-08-07 | $35.73M 10-Q · filed 2019-08-07 | $50.81M derived: sum of 3 quarters · filed 2020-02-26 | $64.86M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $17.35M 10-Q · filed 2019-05-09 | $32.42M derived: sum of 2 quarters · filed 2020-02-26 | $46.48M derived: sum of 3 quarters · filed 2020-02-26 | $60.14M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $15.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $29.13M derived: sum of 2 quarters · filed 2020-02-26 | $42.80M derived: sum of 3 quarters · filed 2020-02-26 | $53.88M 10-K · filed 2020-02-26 |
| 2017-09-30 | $14.05M 10-Q · filed 2018-11-07 | $27.72M derived: sum of 2 quarters · filed 2018-11-07 | $38.81M 10-Q · filed 2018-11-07 | $47.95M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $13.67M 10-Q · filed 2018-08-08 | $24.75M 10-Q · filed 2018-08-08 | $33.89M derived: sum of 3 quarters · filed 2019-02-28 | $39.59M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $11.08M 10-Q · filed 2018-05-03 | $20.23M derived: sum of 2 quarters · filed 2019-02-28 | $25.92M derived: sum of 3 quarters · filed 2019-02-28 | $32.37M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $9.14M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $14.84M derived: sum of 2 quarters · filed 2019-02-28 | $21.29M derived: sum of 3 quarters · filed 2019-02-28 | $25.16M 10-K · filed 2019-02-28 |
| 2016-09-30 | $5.70M 10-Q · filed 2017-11-08 | $12.15M derived: sum of 2 quarters · filed 2017-11-08 | $16.02M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $6.45M 10-Q · filed 2017-08-09 | $10.33M 10-Q · filed 2017-08-09 | ||
| 2015-12-31 | $12.73M 10-K · filed 2018-02-21 |